» Articles » PMID: 38474054

5'-Isoforms of MiR-1246 Have Distinct Targets and Stronger Functional Impact Compared with Canonical MiR-1246 in Colorectal Cancer Cells In Vitro

Abstract

Colorectal cancer (CRC) is a multifactorial disease involving genetic and epigenetic factors, such as miRNAs. Sequencing-based studies have revealed that miRNAs have many isoforms (isomiRs) with modifications at the 3'- and 5'-ends or in the middle, resulting in distinct targetomes and, consequently, functions. In the present study, we aimed to evaluate the putative targets and functional role of miR-1246 and its two 5'-isoforms (ISO-miR-1246_a and ISO-miR-1246_G) in vitro. Commercial Caco-2 cells of CRC origin were analyzed for the expression of WT-miR-1246 and its 5'-isoforms using small RNA sequencing data, and the overabundance of the two miR-1246 isoforms was determined in cells. The transcriptome analysis of Caco-2 cells transfected with WT-miR-1246, ISO-miR-1246_G, and ISO-miR-1246_a indicated the minor overlap of the targetomes between the studied miRNA isoforms. Consequently, an enrichment analysis showed the involvement of the potential targets of the miR-1246 isoforms in distinct signaling pathways. Cancer-related pathways were predominantly more enriched in dysregulated genes in ISO-miR-1246_G and ISO-miR-1246_a, whereas cell cycle pathways were more enriched in WT-miR-1246. The functional analysis of WT-miR-1246 and its two 5'-isoforms revealed that the inhibition of any of these molecules had a tumor-suppressive role (reduced cell viability and migration and promotion of early cell apoptosis) in CRC cells. However, the 5'-isoforms had a stronger effect on viability compared with WT-miR-1246. To conclude, this research shows that WT-miR-1246 and its two 5'-isoforms have different targetomes and are involved in distinct signaling pathways but collectively play an important role in CRC pathogenesis.

References
1.
Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View

2.
Sun Z, Zhang Q, Yuan W, Li X, Chen C, Guo Y . MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis. J Exp Clin Cancer Res. 2020; 39(1):250. PMC: 7678148. DOI: 10.1186/s13046-020-01705-9. View

3.
He Y, Sun M, Zhang G, Yang J, Chen K, Xu W . Targeting PI3K/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021; 6(1):425. PMC: 8677728. DOI: 10.1038/s41392-021-00828-5. View

4.
Gyvyte U, Lukosevicius R, Inciuraite R, Streleckiene G, Gudoityte G, Bekampyte J . The Role of miR-375-3p and miR-200b-3p in Gastrointestinal Stromal Tumors. Int J Mol Sci. 2020; 21(14). PMC: 7404198. DOI: 10.3390/ijms21145151. View

5.
Xu Y, Hannafon B, Khatri U, Gin A, Ding W . The origin of exosomal miR-1246 in human cancer cells. RNA Biol. 2019; 16(6):770-784. PMC: 6546371. DOI: 10.1080/15476286.2019.1585738. View